Microencapsulation is becoming increasingly important in pharmaceutical, cosmetics, food and agricultural industries. New dosage forms are emerging and the efficacy is increasing. Precise metering techniques in the low-volume range are a necessary prerequisite for the production and processing of APIs. Metering pumps by HNP Mikrosysteme are a suitable technical solution.
Sysmex America products on display throughout the Expo at Booth #2802 in Chicago; Product Demonstrations and Educational Opportunities throughout the Show
OPTI Medical Systems will be displaying their next generation of blood gas and electrolyte analyzer at the 2022 AACC Clinical Lab Expo (booth #631). The OPTI® CCA-TS2 Blood Gas and Electrolyte Analyzer provides fast accurate results for blood gases, acid-base balance, electrolytes, ionized calcium, glucose, BUN/urea, lactate and additional blood parameters such as total hemoglobin concentration (direct measurement) and oxygen saturation (sO2). The instrument runs samples of whole blood, plasma, and serum on single-use disposable cassettes.
OPTI Medical Systems B-Lac Cassette measures lactate, pH, PCO2, PO2, tHb, and SO2 in whole blood.
The OPTI® SARS-CoV-2 RT-PCR Test has received FDA Emergency Use Authorization and CE-IVD for sample handling using the OPTI® Rapid Lysis Buffer.
The OPTI® SARS-CoV-2 RT-PCR Test has received FDA Emergency Use Authorization and CE-IVD for pooled testing and asymptomatic screening.
The US Food and Drug Administration granted OPTI Medical Emergency Use Authorization for the OPTI® SARS-CoV-2/Influenza A/B RT-PCR Test on April 21st.
Earlier this year, Lighthouse Lab Services conducted it's first survey of wage and morale among Medical Laboratory Professionals, gathering responses from more than 1,100 individuals across the industry. Our results, which are now available in the report linked below, show a majority of our inaugural respondents are feeling overworked and are performing in understaffed labs, despite most receiving modest bumps in compensation when compared to 2021 salaries. Overall, our results show an industry that continues to struggle to replace retiring lab professionals at a sustainable rate while also facing challenges created by the recent pandemic. Although many are receiving annual compensation increases of 1% to 5%, a number of respondents indicated better salaries could help to alleviate the recruitment problem.
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that the impact factor of its journal Clinical Chemistry has risen to 12.167 in the 2021 Clarivate Journal Citation Reports. This impact factor places Clinical Chemistry in the top 2% of 21,430 ranked academic journals and reaffirms that it is the top journal on medical laboratory technology—a position it has held for more than a decade.
AACC is pleased to announce that Erika Cheung and Tyler Shultz—two of the key whistleblowers who helped bring down Theranos—will speak in a special fireside chat at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago. In this session, Cheung and Shultz will discuss the ethical challenges they faced in their efforts to reveal Theranos’ fraud and protect patients from the company’s faulty tests.
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that Octavia Peck Palmer, PhD, FAACC, has been elected to serve on the AACC board of directors as president-elect starting in August 2022.
AACC joins more than 100 other medical and patient organizations that have expressed concerns about the Senate HELP committee rushing to pass the VALID Act, a bill that would limit patient access to vital laboratory developed tests and the lifesaving diagnoses these tests enable. Specifically, the medical and patient communities urge Congress to remove the VALID Act from the FDASLA Act, a piece of must-pass legislation that the Senate is on the cusp of ratifying.
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the recipients of the 2022 AACC and AACC Academy Awards. Through this annual awards program, AACC and its academy recognize individuals around the world for outstanding research and service in the field of laboratory medicine, and strive to raise awareness of the vital contribution made by all lab professionals to patient care.
AACC has sent comments to the U.S. Senate Health, Education, Labor & Pensions (HELP) Committee urging the committee not to include the VALID Act in its omnibus Food and Drug Administration (FDA) user fee legislation. VALID would limit the availability of vital laboratory-developed tests, decreasing patient access to life-saving diagnostic tools.
A pioneering study published today in AACC’s The Journal of Applied Laboratory Medicine has established transgender reference intervals for common clinical laboratory tests.
A groundbreaking study published today in JAMA demonstrates significant inconsistencies with pediatric reference intervals, which are essential to high quality pediatric medical testing. Completed by AACC’s laboratory medicine experts, this study identifies some of the most pressing issues in this area, thereby paving the way for the medical community to develop more reliable pediatric reference intervals and vastly improve children’s medical care.
We share the FDA’s goal of alerting the public to the potential misuse of non-invasive prenatal screening (NIPS) tests. This is why we’ve been advocating for the modernization of how laboratory-developed tests (LDTs) are regulated by the Centers for Medicare and Medicaid Services (CMS).
A novel study published today in AACC’s Clinical Chemistry journal shows that a machine learning-based test detects emerging synthetic cannabinoids with greater ease than standard methods. By making it simpler to identify new synthetic cannabinoids, this innovative screening test could significantly improve the ability of health professionals and lawmakers to protect the public from these potentially dangerous designer drugs.
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce a new collaboration to host AACC Middle East: A partnership between AACC and Life Diagnostics. This event will bring AACC’s world-renowned education and scientific programs paired with a dynamic exhibit to Dubai, UAE, November 5-6, 2022.
Breaking research published today in AACC’s Clinical Chemistry journal shows that a new test can measure the amount of DNA damage in sperm with greater accuracy than current tests. This new method could significantly improve diagnosis of male infertility, which is more important than ever now that infertility rates are mounting.
For histology and cytology applications, including storage and transport of tissues and samples
At the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, September 26-30, AACC was proud to welcome thousands of laboratory medicine professionals, all of whom have been on the frontlines of COVID-19 testing. The meeting gave the laboratory medicine community a much-needed opportunity to come together safely and in-person to share lessons learned from the pandemic to date, and to discover what’s on the horizon for COVID-19 diagnosis and treatment.
Two new studies presented today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo reveal how antibodies against the SARS-CoV-2 virus can vary among recipients of different COVID-19 vaccines and naturally infected individuals. The findings provide critical data about the immune response to COVID-19 vaccines that could inform future diagnostic research and vaccination efforts.
A groundbreaking study shows that a new rapid test identifies COVID-19 patients who will deteriorate with greater accuracy than existing tests, thus helping patients to get life-saving treatment. Findings on this method, as well as a novel study on the performance of coronavirus tests in children, were presented today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.
Today SCIENION, a BICO company, announced it has entered into a strategic collaboration with diagnostic biotechnology company Pictor Limited to commercialize a high throughput SARS-CoV-2 antibody testing system. In the collaboration, the two companies will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test to create the only platform capable of testing both anti-nucleocapsid and anti-spike antibodies in one reaction. This analysis will be key to support the sustained fight against the pandemic by measuring the population’s level of herd immunity through natural infections and vaccinations.
SCHOTT MINIFAB, a subsidiary of SCHOTT that develops and manufactures microfluidic devices for point-of-care and life sciences consumables, has had a long-standing close customer relationship with Applied Microarrays Inc. (AMI). Together, they develop biotech substrates for diagnostics applications.
20/20 GeneSystems, Inc., (“20/20”), announced the launch of its Clinical Lab Innovation Axcellerator (CLIAx), believed to be the first shared CLIA laboratory facility geared to helping diagnostic test innovators worldwide substantially reduce the time and cost of launching their tests in the U.S.
Research presented today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo shows that a new test could identify healthcare professionals who are experiencing high levels of work-related stress and anxiety. As COVID-19 cases surge again, this test could play a critical role in helping healthcare professionals on the frontlines of the pandemic to get essential mental health support.
Two research teams have developed new noninvasive tests that use either blood or saliva samples to diagnose cases of colorectal cancer or prostate cancer, respectively. Presented today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, these tests could facilitate screening efforts for colorectal cancer and allow clinicians to better distinguish early-stage prostate cancer from more benign prostate conditions.
Veravas has announced the development of its VeraPrep™ Antibody Detection Kit, a new development platform that provides scientists with a state-of-the-art research tool to detect and measure immunoglobulins against new and emerging pathogens.
Rhinostics and Hamilton are combining their respective strengths to improve the speed and quality of nasal sample workflows. As a result of automating swab decapping and assay plate layout, laboratories can drop labor costs by 90% while increasing sample throughput to create scalable and flexible solutions to meet the evolving needs of COVID-19 testing.
Scientists have created a new machine learning tool that could help healthcare workers to quickly screen and direct the flow of COVID-19 patients arriving at hospitals. Results from an evaluation of this algorithm, along with an artificial intelligence method that improves test utilization and reimbursement, were presented today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.
Scientists have created a new test to measure antibodies in girls who have received a vaccine for human papilloma virus (HPV), the leading cause of cervical cancer in women. This new test and a second study establishing accurate reference intervals for pregnant patients were presented today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, and could help resolve persistent challenges in healthcare and lab testing for women.
At the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory medicine experts will present the cutting-edge research and technology that is revolutionizing clinical testing and patient care.
TE Connectivity, a world leader in connectors and sensors, has acquired three companies focused on microfluidic cartridge and blister reagent package development, usability testing, clinical research and manufacturing. The companies are Toolbox Medical Innovations (USA), Wi Inc (USA) and microiLIQUID (Spain). The combined entities leverage design and manufacturing capabilities in the United States and Europe and are focused on serving a global client base ranging from startups to multinationals in the life science, IVD and cell therapy markets.
Clip Health has rebranded from Luminostics ahead of exciting product launches this fall.
MEDICA 2021 trade fair in Dusseldorf, Germany
When lives are at stake, there is no margin for error.
Immune-serology Laboratories Require Consistent Ultrapure Water
Lighthouse Lab Services, the nation’s leading and full-service medical laboratory consulting and recruiting firm, is pleased to highlight its dual acquisitions of Vachette Pathology and Burns Consulting Group in 2021. With these acquisitions, Lighthouse has added new revenue cycle management consulting and managed care contracting services to its existing offerings for the clinical laboratory and pathology community. The company’s growth was also highlighted in Inc. Magazine’s 2021 Inc. 5000 list, which annually honors the country’s fastest growing private companies. Lighthouse President Jon Harol will be available at the 2021 AACC Lab Expo to take questions on the company’s recent expansion and new lines of service.
Opentrons, the lab automation platform comprised of Opentrons Robotics, Pandemic Response Lab, Neochromosome, and Zenith AI, receives $200 million to scale its platform for life sciences and healthcare.
The Nexera QX Multiplex LC-MS/MS System uses multiple, alternating sample introduction streams for continuous operation of the mass spectrometer to significantly increase laboratory throughput and profitability.
Fluid Metering Inc. a microfluidic solutions provider is pleased to introduce the FVD series of variable dispense pumps (patent pending).
Omega Bio-tek, a leading nucleic acid purification kit manufacturer, releases an automation-ready, prefilled DNA extraction kit for magnetic processors to purify DNA faster and easier than before. The convenient Mag-Bind® Blood & Tissue DNA HDQ Prefilled 96 Kit comes prefilled with magnetic beads, reagent plates, and tip combs and aims to simplify setup and processing time for magnetic processors such as the Thermo Fisher Scientific KingFisher™ Flex, Qiagen BioSprint®, and the Applied Biosystems MagMax® Express-96.
Fapon Biotech, a mainstream COVID-19 raw materials supplier to the global top-profile reagent manufacturers, introduced pioneering COVID-19 antibodies for antigen lateral flow testing to detect and differentiate COVID-19 and the most notable variant B.1.1.7 (also known as SARS-CoV-2 VUI 202012/01) in human samples.
DiaPharma Group is pleased to announce our lineup of featured products during AACC 2021. Explore assays for COVID-19-associated coagulopathy, specialty hemostasis, organ injury, and SARS-CoV-2 serology. DiaPharma specializes in assays and mechanistic biomarkers for bleeding and clotting disorders, hemostasis analyzers, liver disease (Nonalcoholic Steatohepatitis, Alcoholic Hepatitis), drug-induced liver and kidney injury, and anti-cancer drug development.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
